AnaptysBio
ANAB
ANAB
177 hedge funds and large institutions have $1.42B invested in AnaptysBio in 2025 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 51 increasing their positions, 65 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less call options, than puts
Call options by funds: $20.8M | Put options by funds: $24.2M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
22% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 65
Holders
177
Holding in Top 10
4
Calls
$20.8M
Puts
$24.2M
Top Buyers
| 1 | +$17.3M | |
| 2 | +$12.5M | |
| 3 | +$8.57M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$7.38M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.02M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$25.7M | |
| 3 | -$20.3M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$19.1M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$13.4M |
